Dong Kim

Dong Kim

No open positions remaining
49 year
Health Technology
Consumer Services
Commercial Services

Profile

Dong Kim formerly worked at Strides Pharma, Inc., as Director & Head-Finance from 2020 to 2021, Tharimmune, Inc., as Chief Financial Officer in 2025, Deloitte & Touche LLP, as Manager-Audit & Assurance from 2005 to 2010, Sun Pharmaceutical Industries, Inc., as Controller from 2019 to 2020, Zoetis, Inc., as Controller from 2018 to 2019, and UroGen Pharma Ltd., as Chief Financial & Accounting Officer from 2022 to 2024.
Mr. Kim received his Masters Business Admin degree from The University of North Carolina at Chapel Hill and undergraduate degree from Yonsei University.

Former positions of Dong Kim

CompaniesPositionEnd
CANTON STRATEGIC HOLDINGS, INC. Director of Finance/CFO 2025-06-09
UROGEN PHARMA LTD. Director of Finance/CFO 2024-10-07
Director/Board Member 2021-07-31
Comptroller/Controller/Auditor 2020-03-31
ZOETIS INC. Comptroller/Controller/Auditor 2019-06-30
See the detail of Dong Kim's experience

Training of Dong Kim

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

90

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology